Technological developments have made possible extension of polymerase chain reaction (PCR) analysis to individual cells to localize DNAlRNA with non-radioactive labels at the light microscopic level. This approach, in situ PCR, is particularly useful in resolving low-frequency message expression in mixed populations of cells and tissues. We have established a working protocol for direct in situ PCR and have utilized m r a l controls to validate our results. In this report we outline the procedures for detecting either DNA or RNA in a rapid and reproducible manner. We evaluate the sequential steps required for this analysis, such as protease hydrolysis, DNAse digestion, "hot start" capabilities, and detection methods. We have applied these methods in several applications, including detection of the p53 gene in human tumor samples, localization of insulin-like growth factor-IA mRNA in cell lines with low levels of expression, and distribution of vansfemin mRNA in lung cancer cell h a and tumors. We demonstrate from this study that the in situ PCR technique is an investigative approach capable of detecting specific DNAlRNA sequences at the cellular level and of identifying cells with low levels of mRNA expression. Cytochem 43:739-747, 1995) 
Introduction
The need to identlfy in tissue samples which cell type contains a particular nucleic acid g a x birth to in situ hybridization techniques, which represent the histochemical counterparts to Northern and Southern blot analysis in molecular biology (Gibson and Polak, 1990) . These techniques gave investigators the ability to delineate which cells in a mixed population express the mRNA of interest. However, constraints on the detection limits of the assay minimize its effectiveness in evaluating low-level nucleic acid expression.
The development of the polymerase chain reaction (PCR) produced a technological breakthrough in nucleic acid detection by increasing molecular sensitivity capabilities (Mullis and Falcona, 1987) , and several laboratories began to combine PCR with in situ hybridization strategies, resulting in the development of in situ PCR methodologies (e.g., Patterson et al., 1994; Staecker et al., 19%; Gosden and Hanratty, 1993; Bagasra et al., 1992; Chiu et al., 1992;  Supported by a grant from the Spanish Ministry of Science (pf93- Komminoth et al., 1992; Nuovo, 1992a) . The investigative power of this technique is especially noteworthy when the copy number of a target nucleic acid is very low, as happens with the expression of insulin-like growth factor-I (IGF-I) in tumor cell lines (Reeve et al., 1992) (Figure 1 ) or when different forms of nucleic acids must be distinguished. Although in theory in situ PCR offers broadreaching capabilities, its full potential has been hampered by the absence of reliable multislide thermocycler instruments capable of yielding reproducible data.
In this report we present our experience with a commercially available thermocycler for tissue sections, review our established in situ PCR protocols, and systematically evaluate the steps required for reliable detection of DNA and RNA. This report demonstrates our methodology for several targets, including p53, IGF-IA, and transferrin in normal and malignant environments. Confirmation of in situ PCR product identity is accomplished by in situ hybridization with a nested 32P-labeled probe or by examining the products using Southern blot analysis to corroborate predicted base pair size. Coordinate uanscriptional/wlational expression was demonstrated by sequential in situ RT-PCR/immunohistochemical analyses on serial sections. Implementation of validated controls and procedures enables the direct in situ PCR procedure to be used as a standardized approach for molecular examination of pathology specimens. ) for IGF-lA in poly A+ RNA from lung, liver, and several cell lines. All cell lines were negative by Northern analysis, but three of four showed IFG-IA expression after RT-PCR amplification.
Materials and Methods

Ceff Lines
Five cell lines were used in this study: NCI-H2087, H345. H720, MCF7 and H2380. These cell lines were grown under protein-free and hormonefree conditions using phenol red-free RPMI-1640 containing 30 nM selenium and 10 mM L-glutamine (Siegfried et al., 1994) . Pellets of approximately 5 x lo6 cells were washed in PBS, re-suspended in 1 ml of 2% NuSieve low melting-point agarosc (Cat. 50082. Lot 626592; FMC BioProducts, Rockland, ME), allowed to solidify, fixed for 2 hr in 4% paraformaldehyde or 10% formalin, and embedded in paraffin by routine histopathology techniques.
Archive Blocks
Ten formalin-fixed, paraffin-embedded blocks containing normal liver and representative cases of lung tumors were obtained from the files of the NCI Navy Medical Oncology branch, National Naval Medical Center, Bethesda. MD .
Immunohistochemistry
A rabbit polyclonal anti-transferrin antibody (Cat AO61, Lot 040) was purchaxd from Dako (Carpintcria, CA) . The avidin-biotin histochemical staining procedure (Hsu et al., 1981) was u x d to localize transferrin immunoreactivity in lung tissue and cell lines using the Vcctastain ABC kit (Cat PK-4001; Vector Laboratories. Burlingame, CA) with a 0.03% solution of 3,3'diaminobenzidine (Cat. D-5637, Lot 122H3642; Sigma, St Louis. MO) and 0.006% H202 as the enzyme substrates.
R N A Extraction
The guanidine isothiocyanate-cesium chloride method of Glisin et al. (1974) was used to extract total RNA from the cell lines. Poly A+ RNA from normal human brain (Cat. 6516-2, Lot 2Y081). liver (Cat. 6510-2, Lot 33076). lung(Cat. 6524-2. Lot 34401). stomach (Cat. 6548-2. Lot 38131). and uterus (Cat. 6537-2. Lot 29100) were purchased from Clontech Laboratories (Palo Alto, CA).
Northern Bfot
Standard formaldehyde gels were run with total RNA (10 pglwell) at 120 v. 100 mAmp for 3 hr. At the end of the run, the gels were washed for 15 min in 20 x SSC and then blotted overnight by capillary flow transfer onto a 0.45-pm nitrocellulose filter (Davis et al., 1986) . The blots were UV crosslinked at 1200 Joules and pre-hybridized for 4 hr. The Stratagene Prime-It kit (Stratagene; La Jolla, CA) was used to label the probe (Table 1) with [32P]-dCTP. Probe (1 x lo6 cpm) was added to each ml of hybridizing buffer. After overnight hybridization, the blot was washed once in 2 x SSCIO.l% SDS at room temperature (RT: 30 min) and once with 0.1% SSCIO.1% SDS at 60'C (30 min). The blots were then air-dried and autoradiographed at -80°C on Kodak XAR5 film for 1-2 days.
Standard PCR
Oligonucleotide primers for IGFIA, p53, and transferrin were made in house using a MilliGcn 8700 DNA synthesizer (Millipore; Marlborough, MA). Sequences are shown in Table 1 . All buffers, enzymes, and nucleotides used were obtained from Applied Biosystems (Perkin-Elmer Cetus; Norwalk, CT). A Perkin-Elmer 9600 Thcrmocyclcr was used to amplify the samples.
PCR products wcre analyzed electrophoretically using a 1% agarosc gcl(80 V, 3 hr) and the ethidium bromide staining was observed under w light, followed by Southern analysis with nested 32P-labeled probes.
Southern Anafysis
Gels were denatured in 1.5 M NaCI10.6 M NaOH and 1.5 M NaClI2 M Tris and blotted onto a 0.2-pm nitrocellulose filter in 20 x SSC by capillary flow transfer overnight. The filter was cross-linked at 80'C under vacuum and put in hybridization buffer. Anti-sense nested probes were end-labeled by standard j2P procedures (Sambrook et al.. 1989) . Hybridization with the probe was done overnight at 42°C. Stringency washing at RT was in 5 x SSC/O.l% SDS (twice for 30 min), then 1 x SSCIO.l% SDS (twice for 30 min). Filters were air-dried and autoradiographed at -8O'C on KOdak XAR5 film for 2-4 hr.
In Situ PCR
The in situ PCR technique for localizing specific DNA sequences is performed by a three-step protocol as described by Nuovo (1992a) . After d m -ing the tissue sections, a protein digestion is carried out to facilitate reagent penetration into the cells. The second step consists of the PCR itself with simultaneous labeling of the PCR products, followed by the third step that visualizes the labeled product. The in situ amplification technique for RNA detection utilizes a similar protocol. However, it incorporates two additional steps. After proteinase digestion the tissue is exposed to RNAsefree DNAse to avoid amplification of genomic DNA. Second, the remaining mRNA is reverse-transcribed to form cDNA templates, which are in turn amplified by PCR. To maximize the efficiency of the in situ PCR technique, all of these protocol steps must be optimized for individual experiments. The reverse transcription and the PCR steps were performed using an OmniSlide thermocycler (20-slide capacity) equipped with a heated wash module (National Labnet; Woodbridge, NJ).
Protease Digestion. Depending on the fixative and the nature of the tissue, reagent access to the target nucleic acid can vary. To identify optimal permeability methods, we analyzed enzyme digestion procedures by varying the concentration of proteinase K (Cat. P-0390, Lot 9380603; Sigma) between 1 and 100 pglml and incubation time (5-45 min).
DNAse Digestion. Deoxyribonuclease I Amplification Grade (Cat. 18068-015, Lot EK2409; Gibco BRL, Gaithersburg, MD), 10 Ulslide was used to degrade the DNA according to the manufacturer's specifications. The influence of different digestion times on the quality of the staining was tested Reverse "scription. For this step we used the Superscript Preamplification System (Cat. 18089-011, Lot EKT001; Gibco) following the manufacturer's specifications. In summary, the sections are immersed in a solution containing the random primers, covered with parafilm coverslips, and incubated in the thermocycler for 10 min at 70'C. After removing the coverslips, another solution containing the reverse transcriptase (100 U/section) is added and covered with a new piece of parafilm. The slides are then maintained at RT for 10 min. at 45°C for 45 min, and at 70'c for 10 min.
PCR. Before the in situ PCR experiment, all parameters for the PCR reaction, including MgC12 concentration, pH, and annealing temperature, must be optimized by standard PCR. At this point the PCR products can be cloned and sequenced to confirm identity. Our products were cloned into a pCRII vector (Cat. 2000-01; Invitrogen, San Diego, CA) and sequenced with the dsDNA Cycle Sequencing Kit (Cat. 81965A, Lot CAC 108; Gibco). Optimization of conditions favoring single band production is advised, because it is not possible to distinguish PCR products of different molecular weights in the tissue sections. To eliminate the possibility of generating PCR products from genomic DNA, it is important to design primers that bridge introns so as to distingush template source on the basis of product size.
Synchronized "hot start" PCR (Nuovo, 1992b) was achieved using the Taq neutralizing antibody technique (Kellogg et al., 1994) . Taq-blocking monoclonal antibody was purchased from Clontech (TaqStart antibody; Cat. 5400-1. Lot 47656). We compared this procedure with classical methods for PCR and chose the antibody protocol because it requires less manipulation of the sections.
For the analyses described here we used the following PCR mixture: 2.5 mM MgC12, 200 pM dNTPs, 100 pM digoxigenin-ll-2'-deoxyuridine->'-triphosphate (Cat. 1558 706, Lot 13945241-12; Boehringer Mannheim, Indianapolis, IN), 1 ng/p1 primers, 50 mM KCI, 10 mM Tris-HC1, pH 8.3. An 80-pl aliquot of solution was applied to each slide, and then each slide was covered by silanated glass coverslips. sealed with rubber cement, and placed in the thermocycler. For the targets we amplified, 15-20 cycles were adequate to obtain crisp staining. After DNA amplification, two washes in 0.1 x SSC at 45'C, 20 min each, were performed to eliminate unbound nucleotides.
Development of Digoxigenin. Detection of digoxigenin-tagged PCR products was done with a kit from Boehringer Mannheim (Cat. 1210 220, Lot. 14101420-13). It involves a 2-hr incubation with an anti-digoxigenin antibody bound to alkaline phosphatase. After a thorough rinse, the appropriate substrates (nitroblue tetrazolium and 5-bromo-chloro-3-indolylphosphate) were enzymatically transformed into a dark-blue precipitate. Color deposition was checked under the microscope.
Recently, it has been observed that polyvinyl alcohol enhances the intensity of the alkaline phosphatase-nitroblue tetrazolium reaction and prevents diffusion of the precipitate (Barth and Ivarie, 1994; De Block and Debrouwer, 1993) . We took advantage of this technique to increase the dilution of the anti-digoxigenin antibody to 1:2000 (instead of the usual 1:500 recommended by the manufacturer), obtaining considerable background reduction.
Controls. The PCR technique is well known for its ability to amplify even single copies of DNA in a sample, contaminants included. Therefore, the precautions recommended for routine PCR regarding scrupulous care with cleanliness, use of a dedicated set of pipettes, and preparation of the PCR mixture away from the amplification area (Orrego, 1990) are also applicable for in situ PCR. In addition, working with tissue sections adds new concerns, such as heterogeneous application of reagents, bubbles, drying of the boundaries, and stability of the nucleic acids during the preparation of the samples. As in any biological experiment, attention to appropriate controls is of paramount importance for successful interpretation of results and this is particularly true for in situ PCR analysis.
At least three types of controls are needed in every experiment to avoid false-positives or -negatives.
Positive Control. Include a section from a block that was previously positive for the same set of primers. If this is the first time that these primers are being used, include a section of a well-fixed tissue or cell line known to have a high expression of the target nucleic acid as determined by other techniques (e.g., Northern analysis, standard PCR, in situ hybridization).
Negative Control. Omission of the reverse transcription andlor RNAse treatment will yield information about nonspecific amplification of remaining nuclear or mitochondrial DNA.
Negutive Control. Omission of the primers in the PCR mixture will reveal nonspecific staining due to endogenous priming: DNA fragments produced by the exonuclease activity of the DNA polymerase or by apoptosis (Gold et al., 1993) . and other artifacts such as intrinsic alkaline phosphatase activity.
An additional control consists of establishing existing relationship between the transcriptional/uanslational products. This can be done by staining one section for the nucleic acid by in situ PCR and a serial section with a specific antibody against the polypeptide. The co-localization ofthe mRNA and its protein within the same cells will strengthen the validity of the observation.
Confirmation of in situ PCR product integrity can be achieved in two ways: (a) It is possible to scrape the tissue off the glass slide after in situ PCR, to extract the DNA (we used TRIzol reagent, Cat. 5596UA. Lot DPU 201; Gibco), and to analyze by agarose gel electrophoresis and Southern blot with the appropriate radioactive probe. Cloning and sequencing of this product is also possible, after several additional PCR cycles to yield products without modified bases. (b) We tested product identity by performing in situ hybridization with a 32P-labeled nested probe after the amplification. This procedure is routinely used for indirect in situ PCR (Patterson et al., 1994; Walter et al., 1994) . Figures 2-4 ,7-9, and 11 were photographed with a Nikon Labophot-2 microscope, obtaining 35-mm color slides. To prepare the composite figures preserving the original colors, we used a digital imaging system. The chosen slides were digitalized in a Nikon LS-3510 scanner and the resulting images were cropped and aligned with the software program Adobe Photoshop, version 2.5, in a Macintosh Quadra 700 computer. A Kodak XLT 7720 calor printer was used to print the final composite. 
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Results
In our work with the three sets of primers described in Table 1 , we optimized all the steps involved in the in situ localization of the target nucleic acids. Here we offer a summary of our findings.
Fiwztion
Of the two furatives tested, 4% paraformaldehyde gave stronger staining and appears to be better for preserving both tissue morphology and nucleic acid integrity, rather than 10% formalin. The fixation step is especially critical in dealing with RNA.
Protease Dkestion
Usually a short exposure to the protease yielded poor permeabilitation and too long digestions resulted in tissue damage and lower stain intensity (Figure 2) . For most applications a concentration of 10 pg/ml of proteinase K at 37% for 15 min is an appropriate starting point. However, when the target nucleic acid is located in the nucleus, as in the case of the p53 gene (Figure 3) , proteinase K digestions must be longer. In addition, tissue fixed in 10% formalin requires a longer digestion time than tissue fixed in 4% paraformaldehyde.
DNAse Digestion
Before performing the reverse transcription procedure, degradation of the existing DNA is usually recommended to avoid amplification of nuclear components. Nevertheless, we have repeatedly observed that if the DNA digestion is incomplete, nonspecific nuclear staining appears (Figure 4 ). An incubation time analysis is recommended, and on some occasions the omission of this step may be required to avoid the problem. Figure 5 . This procedure is advised because it is not possible to distinguish PCR products of different molecular weights in the tissue sections. An important factor is the length of the PCR product. When primers generating a 1400 BP product were used (results not shown) no staining was observed, although they worked perfectly in regular PCR. In our experience, products smaller than 600 BP are best. When we compared three different methods to initiate the PCR reaction ( Figure 6 ). we observed that the method involving theTaq-Start antibody yielded higher amounts of PCR product. For in situ PCR we applied identical parameters to those performed in standard PCR. but fewer cycles were needed to obtain effective staining. If the number of cycles was excessive, the staining could cover important morphological features and nonspecific amplification could take place (Figure 7) .
Co n trols
Several examples of how to control the in situ RT-PCR experiments are shown in Figures 8-11 . Negative controls were done by omitting either the enzyme during reverse transcription ( Figure 8B) or the primers in the PCR mixture ( Figure 8C ). Another approach to further validate in situ RT-PCR results was to perform overlapping alignment of immunostained protein products in serial sec-
Brain
Stomach Uterus ---1 2 3 1 2 3 1 2 3 ,I -452bp Figure 6 . Standard RT-PCR for transferrin in human brain. stomach and uterus using three different PCR methods: (1) the classic "hot start" procedures, (2) no "hot start" and (3) blockade of the polymerase by the "TaqStart" antibody. The third band for each organ is stronger than the others. tions (Figure 9 ). Finally, to confirm that the PCR products obtained in situ were the expected ones, we did Southern blot analysis (Figure 10) . This control ensures that the PCR product obtained in situ has the expected size, although the product bands are broadened by incorporation of different numbers of digoxigenin-labeled nucleotides. The other way to confirm product identity is hybridization with a nested radioactive probe (Figure 11) .
The test examples shown in this report were chosen to illustrate the methodological issues. Wild-type p53 was present in the nuclei of all normal and tumor cells studied (Figure 3) . The in situ RT-PCR technique was able to demonstrate expression of IGF-I in sources producing both high levels (liver; Figure 2 ) and low levels (tumor cell lines ; Figures i, 10, and 11 ) of the mRNA. Finally. the application of in situ RT-PCR to transferrin showed expression of its mRNA in all the cell lines tested and in seven of nine cases of lung tumors. A clear correlation with immunohistochemical results was always observed (Figure 9 ).
Discussion
In situ PCR is a relatively new technique with impressive possibilities and fields of application. It combines the specificity of in situ hybridization and the sensitivity of PCR and now, with reliable multislide thermocyclen available, can be a very reproducible technique. Several companies offer thermocyclers for in situ PCR (e.g., Coy, MJ Research, Perkin Elmer, National Labnet). We reviewed a few of these models before beginning these experiments and selected the OmniSlide System based on ease and flexibility of operation, slide number capacity, and field of view during horizontal incubations. A general protocol for in situ amplification in the Omni-Slide thermocycler is reported in the present study.
Two main protocols, direct and indirect, have been described for in situ PCR. In the direct approach a labeled nucleotide is incorporated into the PCR products, whereas in the indirect method a subsequent in situ hybridization with a labeled probe is required to visualize the products . We chose the direct method because it is shorter, less expensive, and minimizes manipulation of the tissue, which can result in detachment and loss of the sections. Some authors point out that direct methods can result in false-positive results al., 1993), but we have demonstrated that use of the proper controls will eliminate this problem.
There have been discrepancies with regard to which fixative is better for in situ PCR. Klimecki et al. (1994) have reported that when tissue sections were digested and standard PCR was done, alcohol-containing fmtives yielded higher PCR product levels than in situ PCR all the labeled product ended up in the supernatant, whereas formalin-fued tissues were able to retain the PCR product, possibly owing to the lattice created by the fmtive-induced cross-linking. Based on our experience with in situ hybridization (Steel et al., 1994; Martinez et al., 1993) and the data presented here with in situ PCR, we found 4% paraformaldehyde the best fixative to preserve the integrity of both tissue morphology and nucleic acids. The importance of optimizing the protein digestion step has been pointed out by other authors (Chen and Fuggle, 1993; Nuovo 4 et al., 1993) , who reported that protease overdigestion can result in migration of the PCR products from the cells. We show here that overdigestion also results in loss of tissue architecture.
The DNAse treatment appears to be the most problematic step, and on some occasions omission of this step is required to avoid nonspecific nuclear staining. This anomaly is probably caused by small fragments of nudear DNA being used as nonspecific primers during the amplification step. When DNAse treatment is omitted from the in situ RT-PCR protocol, we have found that by using a low number of cycles (20 or less) the staining is limited to the cytoplasm.
Differential staining can be optimized owing to the dBerent number of copies present in the nucleus for a given gene (two in a diploid cell) and the number of mRNA copies present in the cytoplasm when the cell is expressing the gene (usually several thousands). If the number of cycles is excessive, both compartments can be stained ( Figure 7A ). Similar observations have been made by other au,hors (Komminoth et al., 1934 (Komminoth et al., , F'atel et al., 1994 . In detecting mRNA expression, it is very easy to determine if nonspecific genomic amplification has occurred, since nuclear staining is not expected. However, in assaying for DNA or viral RNA, additional precautions. such as indirect detection methods or Southern blotting of the PCR products, should be considered .
Some authors recommend for in situ PCR the use of higher concentrations of MgCIz than for solution-phase PCR and the need for BSA in the PCR solution ( N u m et al., 1993) . Although we recognize that in some cases this could be helpful, we did not observe major differences when we varied the MgCIz concentration and, as shown in Figure 5 , these variations could result in amplification of nonspecific products.
In this study we did not carry out an extensive analysis of the &ct of the size of the polymerized product on sensitivity. In our hands, products smaller than 600 BP have always yielded signal, whereas a longer product (1400 BP) did not. The lack of staining when long PCR products are generated could be due to partial damage of the nucleic acids, particularly " A. during processing of the tissue (e.g., fixation. embedding, sectioning). This manipula-'. tion could generate nicks in the target that prevent amplification in a length-dependent manner. The high sensitivity of in situ RT-PCR is exemplified by the strong staining for IGF-IA of the cell line H2380 (Figures 7 and   11 ). Preparations of poly A + RNA from this cell line were negative for IGFI by Northern blot analysis but were positive after RT-PCR ( Figure I) , indicating that in situ PCR could match the sensitivity of standard PCR.
The accuracy of the non-radioactive methods compared with radioactive ones in the localization of nucleic acids can be observed in Figure 11 . The digoxigenin label is restricted to the cytoplasm of the H2380-cells, whereas the autoradiographic grains are widely scattered. This has been frequently noted (Gibson and Polak, 1990) , and the only reason for continuing use of radioactive methods was their higher sensitivity, but this point is not an issue with PCR amplification techniques.
In summary, the advent of reliable slide thermocyclers has made possible reproducible in situ PCR and in situ RT-PCR. This technique can be used in many emerging morphological fields that require high levels of sensitivity, as in the expression of receptors, mapping of differentially spliced RNAs, localization of single point mutations and gene rearrangements, or developmental expression of low copynumber mRNAs. It is not difficult to imagine that this technique will have a promising future in the histopathological field, occupying the same position that standard PCR enjoys in molecular biology.
